Mainz Biomed N.V.
MYNZ
$2.27
$0.0050.22%
NASDAQ
| 12/31/2024 | 03/31/2022 | 12/31/2021 | 09/30/2021 | 06/30/2021 | |
|---|---|---|---|---|---|
| Net Income | 0.00% | -10.27% | 0.00% | -2,477.45% | -454.25% |
| Total Depreciation and Amortization | 0.00% | 269.97% | 0.00% | -49.71% | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 0.00% | -33.45% | 0.00% | 4,311.08% | -- |
| Change in Net Operating Assets | 0.00% | 362.39% | 0.00% | -66.10% | -203.25% |
| Cash from Operations | 0.00% | -109.11% | 0.00% | -1,065.21% | -- |
| Capital Expenditure | 0.00% | -1,968.85% | 0.00% | -32.61% | -- |
| Sale of Property, Plant, and Equipment | 0.00% | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | 0.00% | -- | -- |
| Divestitures | 0.00% | -- | -- | -- | -- |
| Other Investing Activities | 0.00% | -- | -- | -- | -- |
| Cash from Investing | 0.00% | -120.90% | 0.00% | 13,228.26% | -- |
| Total Debt Issued | 0.00% | -- | 0.00% | -98.84% | -- |
| Total Debt Repaid | 0.00% | -321.51% | 0.00% | 22.50% | -- |
| Issuance of Common Stock | 0.00% | 132.59% | 0.00% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 0.00% | 131.79% | 0.00% | 2,294.84% | -- |
| Foreign Exchange rate Adjustments | 0.00% | -643.16% | 0.00% | 230.14% | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 0.00% | 102.51% | 0.00% | 5,776.31% | -- |